Publications
Showing 161 to 170 of 560 Publications
| Title | Authors | Year | Journal |
|---|---|---|---|
| Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression | Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Bandres Ciga S, Gan-Or Z*, Noyce AJ. | 2021 | Movement Disorders |
| International Parkinson’s Disease Genomics C. Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and alpha-synuclein mechanisms. | "Blauwendraat, C., Heilbron, K., Vallerga, CL., Bandres-Ciga, S., von Coelln, R., Pihlstrom, L., Simon-Sanchez, J., Schulte, C., Sharma, M., Krohn, L.*, Siitonen, A., Iwaki, H., Leonard, H., Noyce, AJ., Tan, M., Gibbs, JR., Hernandez, DG., Scholz, SW., Jankovic, J., Shulman, LM., Lesage, S., Corvol, JC., Brice, A., van Hilten, JJ., Marinus, J., Eerola-Rautio J., Tienari P., Majamaa K., Toft M., Grosset DG., Gasser, T., Heutink, P., Shulman, JM., Wood, N., Hardy, J., Morris, HR., Hinds, DA., Gratten, J., Visscher, PM., Gan-Or, Z.**, Nalls, MA., Singleton, AB. " | 2019 | Mov Disord |
| Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative | Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Moscoso Rial A, Pascoal TA, Andreasson U, Scholl M, Weiner H, Rosa-Neto P*, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H, for the Alzheimer's Disease Neuroimaging Initiative | 2020 | Molecular Psychiatry |
| The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease | Pentz R, Iulita MF, Ducatenzeiler A, Benett DA, Cuello AC* | 2020 | Molecular Psychiatry |
| APOEε4 potentiates the relationship between amyloid-β and tau pathologies | Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Savard M, Chamoun M, Thomas E, Kang MS, Lussier F, Tissot C, Soucy JP, Massarweh G, Rej S, Saha-Chaudhuri P, Poirier J*, Gauthier S*, Rosa-Neto P* | 2020 | Molecular Psychiatry |
| High-density lipoproteins suppress Abeta-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture | Robert, J., Button, E. B., Stukas, S., Boyce, G. K., Gibbs, E., Cowan, C. M., Gilmour, M., Cheng, W. H., Soo, S. K., Yuen, B., Bahrabadi, A., Kang, K., Kulic, I., Francis, G., Cashman, N., & Wellington, C. L. | 2017 | Molecular Neurodegeneration |
| Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E | Robert J, Button EB, Martin EM, McAlary L, Gidden Z, Boyce G, Caffrey TM, Agbay A, Clark A, Silverman JM, Cashman NR*, Wellington CL* (Team 3) | 2020 | Molecular Neurodegeneration |
| Plasma Levels of Phosphorylated Tau 181 Are Associated With Cerebral Metabolic Dysfunction in Cognitively Impaired Individuals | Lussier FZ, Benedet AL, Therriault J, Pascoal TA, Tissot C, Chamoun M, Mathotaarachchi S, Savars M, Ashton NJ, Karikari TK, Rodriguez JL, Snellman A, Bezgin G, Kang MS, Arias JF, Wang YT, Gauthier S*, Zetterberg H, Blennow K, Rosa-Neto P* | 2020 | Molecular Neurodegeneration |
| Precocious White Matter Inflammation and Behavioural Inflexibility Precede Learning and Memory Impairment in the TgAPP21 Rat Model of Alzheimer Disease | Levit A, Gibson A, Hough O, Jung Y, Agca Y, Agca C, Hachinski V*, Allman BL, Whitehead SN* | 2021 | Molecular Neurobiology |
| Chloroquine Restores Ganglioside Homeostasis and Improves Pathological and Behavioral Outcomes Post-stroke in the Rat. | Caughlin, S*, Hepburn, J., Liu, Q., Wang, L., Yeung, KK., Cechetto, DF., Whitehead, SN**. | 2019 | Molecular neurobiology |
Showing 161 to 170 of 560 Publications